HOME
ABOUT US
SERVICES
ACCESS
FIND A DOCTOR
CLINICAL RESEARCH
CLINICAL TRIAL
CONTACT
More
An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain From Spinal Cord Injury and Disease
Medicinal cannabis in the treatment of chronic pain
Assessing efficacy of non-opioid analgesics in experimental pain models in healthy volunteers: an updated review
Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy
Cannabinoid CB2 Receptors Regulate Central Sensitization and Pain Responses Associated with Osteoarthritis of the Knee Joint
Cannabinoid–Opioid Interaction in Chronic Pain
Cannabinoid receptors and pain
Cannabinoids delivery systems based on supramolecular inclusion complexes and polymeric nanocapsules for treatment of neuropathic pain
Cannabinoids for Neuropathic Pain
Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials
Cannabinoids in the management of difficult to treat pain
Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS)
Clinical implications for cannabinoid use in the rheumatic diseases: potential for help or harm?
Combined treatment with morphine and Δ9 -tetrahydrocannibinol (THC) in rhesus monkeys: antinociceptive tolerance and withdrawal
Injury, Pain, and Prescription Opioid Use Among Former National Football League (NFL) Players
Overcoming the Bell-Shaped Dose-Response of Cannabidiol by Using Cannabis Extract Enriched in Cannabidiol
Prescribing cannabis for harm reduction
Role of the Cannabinoid System in Pain Control and Therapeutic Implications for the Management of Acute and Chronic Pain Episodes
Role of Cannabinoids in Pain Management
Sex differences in anti-allodynic, anti-hyperalgesic and anti-edema effects of Δ9-tetrahydrocannabinol in the rat
Smoked cannabis for chronic neuropathic pain: a randomized controlled trial
Stable dose cannabinoid medicine (Sativex®, THC+CBD) can provide sustained efficacy in the treatment of refractory painful diabetic neuropathy or other peripheral neuropathic pain associated with allodynia.
Survey Results of Pain Treatments in Adults with Cerebral Palsy
Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine
Targeting CB2 receptors and the endocannabinoid system for the treatment of pain
The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects
The Endocannabinoid System, Cannabinoids, and Pain
The endogenous cannabinoid system and its role in nociceptive behavior
The Pharmacologic and Clinical Effects of Medical Cannabis
Therapeutic Benefits of Cannabis: A Patient Survey
Use of Prescription Pain Medications Among Medical Cannabis Patients: Comparisons of Pain Levels, Functioning, and Patterns of Alcohol and Other Drug Use
δ-Ctenitoxin-Pn1a, a Peptide from Phoneutria nigriventer Spider Venom, Shows Antinociceptive Effect Involving Opioid and Cannabinoid Systems, in Rats
Anti-Inflammatory Role of Cannabidiol and O-1602 in Cerulein-Induced Acute Pancreatitis in Mice
Cannabinoids Ameliorate Pain and Reduce Disease Pathology in Cerulein-Induced Acute Pancreatitis
Cannabinoids Reduce Markers of Inflammation and Fibrosis in Pancreatic Stellate Cells
Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson’s disease patients: a case series
Cannabidiol for the treatment of psychosis in Parkinson’s disease
Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial
GPR55: A therapeutic target for Parkinson's disease?
Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection
Self-Reported Efficacy of Cannabis and Other Complementary Medicine Modalities by Parkinson's Disease Patients in Colorado
Survey on Cannabis Use in Parkinson’s Disease: Subjective Improvement of Motor Symptoms
The CB1 cannabinoid receptor agonist reduces L-DOPA-induced motor fluctuation and ERK1/2 phosphorylation in 6-OHDA-lesioned rats
The influence of cannabinoids on generic traits of neurodegeneration
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
Cannabis as a substitute for prescription drugs – a cross-sectional study
Cannabis in the arm: what can we learn from intravenous cannabinoid studies?
Dietary fats and pharmaceutical lipid excipients increase systemic exposure to orally administered cannabis and cannabis-based medicines
Human Cannabinoid Pharmacokinetics
Pharmacokinetics and metabolism of the plant cannabinoids, delta9-tetrahydrocannabinol, cannabidiol and cannabinol
Association of the Cannabinoid Receptor Gene (CNR1) With ADHD and Post-Traumatic Stress Disorder
Cannabinoids Prevent the Effects of a Footshock Followed by Situational Reminders on Emotional Processing
Changes of endocannabinoid plasma levels following type I trauma: A prospective pilot study
Elevated Brain Cannabinoid CB1 Receptor Availability in Posttraumatic Stress Disorder: A Positron Emission Tomography Study
On Disruption of Fear Memory by Reconsolidation Blockade: Evidence from Cannabidiol Treatment
Preliminary, Open-Label, Pilot Study of Add-On Oral Δ9-Tetrahydrocannabinol in Chronic Post-Traumatic Stress Disorder
PTSD Symptom Reports of Patients Evaluated for the New Mexico Medical Cannabis Program
A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol
An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity
Cannabidiol Enhances the Inhibitory Effects of Δ9-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and Survival
Cannabis and Cannabis Extracts: Greater Than the Sum of Their Parts?
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
A Longitudinal Study of Prenatal Marijuana Use
Cannabidiol changes P-gp and BCRP expression in trophoblast cell lines
Cannabis and Breastfeeding
Endocannabinoid System in First Trimester Placenta: Low FAAH and High CB1 Expression Characterize Spontaneous Miscarriage
Fetal Alcohol Spectrum Disorder: Potential Role of Endocannabinoids Signaling
Five-year follow-up of rural Jamaican children whose mothers used marijuana during pregnancy
Identifying Prenatal Cannabis Exposure and Effects of Concurrent Tobacco Exposure on Neonatal Growth
Lasting impacts of prenatal cannabis exposure and the role of endogenous cannabinoids in the developing brain
Ligand-receptor signaling with endocannabinoids in preimplantation embryo development and implantation
Maternal Marijuana Use During Lactation and Infant Development at One Year
Multiple Roles for the Endocannabinoid System During the Earliest Stages of Life: Pre- and Postnatal Development
Prenatal Marijuana Exposure and Neonatal Outcomes in Jamaica: An Ethnographic Study
The Endocannabinoid-CB Receptor System: Importance for development and in pediatric disease
Transfer of Inhaled Cannabis Into Human Breast Milk
Cannabinoid receptor agonist-induced apoptosis of human prostate cancer cells LNCaP proceeds through sustained activation of ERK1/2 leading to G1 cell cycle arrest
Cannabinoid receptor as a novel target for the treatment of prostate cancer
Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines
Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: Involvement of CB2
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms
Proapoptotic effect of endocannabinoids in prostate cancer cells
The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications
Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis
A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers.
A potential role for psilocybin in the treatment of obsessive-compulsive disorder.
Acute effects of MDMA on trust, cooperative behaviour and empathy: A double-blind, placebo-controlled experiment.
Beckley Foundation for research into cannabis & psychedelics.
Classical psychedelics for the treatment of depression and anxiety: A systematic review.
LSD, madness and healing: Mystical experiences as possible link between psychosis model and therapy model.
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.
Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.
Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study.
Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological Analysis.
Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression.
Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.​
Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression.​
Psychedelics and Psychedelic-Assisted Psychotherapy.​
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression.
Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights from Psychedelic Medicine and Animal Models.
Reviewing the Potential of Psychedelics for the Treatment of PTSD.​
Spontaneous and deliberate creative cognition during and after psilocybin exposure.​
The effect of acutely administered MDMA on subjective and BOLD-fMRI responses to favourite and worst autobiographical memories.​
The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers.​
​Trial of Psilocybin versus Escitalopram for Depression.
Association Between Marijuana Exposure and Pulmonary Function Over 20 Years
Bronchodilator Effect Of Delta1-Tetrahydrocannabinol
Cannabinoid effects on ventilation and breathlessness: A pilot study of efficacy and safety
Does smoking marijuana increase the risk of chronic obstructive pulmonary disease?
Effects of Marijuana Smoking on the Lung
Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma
Inhibition of guinea-pig and human sensory nerve activity and the cough reflex in guinea-pigs by cannabinoid (CB2) receptor activation
Marijuana and chronic obstructive lung disease: a population-based study
Monoacylglycerol Lipase (MAGL) Inhibition Attenuates Acute Lung Injury in Mice
Preclinical Assessment of Novel Therapeutics on the Cough Reflex: Cannabinoid Agonists as Potential Antitussives
The Effects of Marijuana Exposure on Expiratory Airflow A Study of Adults who Participated in the U.S. National Health and Nutrition Examination Study
